DiaSorin S.p.A. DSRLF
92.00 USD 0.00 (+0.00%)
Regular-session close
92.00 Day range 92.00
66.50 52-week range 92.00
- YTD
- +20.99%
- 1 year
- +31.15%
News
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q3 2026 Earnings Call Transcript DiaSorin S.p.A. (DSRLF) Q3 2026 Earnings Call Transcript
defenseworld.net DiaSorin (OTCMKTS:DSRLF) Shares Down 1.7% – Should You Sell? Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) traded down 1.7% during mid-day trading on Friday. The stock traded as low as $84.00 and last traded at $84.00. 5 shares traded hands…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript
defenseworld.net Head to Head Contrast: Perrigo (NYSE:PRGO) and DiaSorin (OTCMKTS:DSRLF) DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Perrigo (NYSE: PRGO - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q4 2025 Earnings Call Transcript DiaSorin S.p.A. (DSRLF) Q4 2025 Earnings Call Transcript
defenseworld.net Head-To-Head Survey: Abbott Laboratories (NYSE:ABT) vs. DiaSorin (OTCMKTS:DSRLF) DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Abbott Laboratories (NYSE: ABT - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based…
defenseworld.net Head-To-Head Review: IM Cannabis (NASDAQ:IMCC) versus DiaSorin (OTCMKTS:DSRLF) DiaSorin (OTCMKTS:DSRLF - Get Free Report) and IM Cannabis (NASDAQ: IMCC - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on…
seekingalpha.com Invesco International Small-Mid Company Fund Q3 2025 Portfolio Positioning Invesco International Small-Mid Company Fund added six new positions and exited 11 positions during the quarter. We are benchmark independent, bottom-up investors, focusing on company fundamentals…
seekingalpha.com DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate DiaSorin's 2024 revenue grew by 3%, with an underlying increase of 7%, and net profit rose to 188.1M EUR, reflecting a 17% EPS increase. The company generated strong free cash flow of 191M EUR,…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2024 Results Conference Call March 14, 2025 12:30 PM ET Company Participants Carlo Rosa - CEO Piergiorgio Pedron - CFO Conference Call Participants Kavya Deshpande -…
reuters.com Italy's DiaSorin ex-Covid revenue in line with guidance Italian medical diagnostics group DiaSorin on Friday reported a 3% rise in 2024 revenue, citing dampened demand for its products with a milder Flu season compared to the previous year.
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
reuters.com Diasorin 2023 revenue drops 14%, in line with guidance; shares fall Italian medical diagnostic group Diasorin on Friday reported a double-digit drop in revenue for 2023, in line with its revenue guidance for the year, but shares dropped as much as 7.3%.
zacks.com New Strong Sell Stocks for January 29th T, DSRLF and HAFC have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2023.
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript DiaSorin S.p.A. (OTCPK:DSRLF) Q3 2023 Earnings Conference Call November 3, 2023 11:30 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q2 2023 Earnings Call Transcript DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
seekingalpha.com DiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call Transcript DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2022 Earnings Conference Call March 27, 2023 9:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
seekingalpha.com DiaSorin: Overvalued Italian Healthcare Company DiaSorin S.p.A. is an Italian healthcare company that develops, produces, and sells reagent kits and analyzer instruments mostly used to detect patients' diseases. DiaSorin benefited from the…
